TEMPEST GRAHAM: Open Payments
NPI 1558084343 · CULPEPER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 15 payments from 12 companies in 2025. Trend: 2023 $107 · 2024 $199 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $86 |
| Lilly USA, LLC | 3 | $79 |
| Exact Sciences Corporation | 2 | $35 |
| Indivior Inc. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $30 |
| ABBVIE INC. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $21 |
| CooperSurgical, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: KEVEYIS, ZEPBOUND, Cologuard Collection Kit, SUBLOCADE, Veozah, QULIPTA, INGREZZA, PREVNAR 20.
Industry payments across VA — which companies pay providers there.
